Technology Converging with Biology
Identify specific examples in which technology is converging with biology (for example, implantables, wearables, and genome editing) to inform a client's decision on potential future investments in technology.
- The most common clinically used implants in the US include artificial smart legs, hearing aids, coronary stents, artificial eye lenses, and artificial knees.
- Other artificial implants in use or development include bionic hands, artificial skin, bladder stimulators, RFID tags, and brain to machine interface.
- Artificial eye lenses are the most common clinically used implant, with about 2.6 million procedures performed annually.
- The procedure costs between $3,200 and $4,500 per eye, and the main manufacturers are Alcon Laboratories, Abbott Laboratories, and Bausch & Lomb.
- Six recent developments in the biotech industry include biosensors, 3-D bioprinting, bioplastics, bioenergy, gene editing, and virtual and augmented reality.
- The Swiss company CRISPR Therapeutics aims to use genetic engineering to improve the lives of people with hereditary diseases.
- 3-D bioprinting has allowed doctors to artificially construct internal organs and implant these into individuals that need them.
- eGenesis is a company that aims to create human organs for transplant using gene editing.
- Genetically engineered viruses have been used to help patients with inherited diseases like Severe Combined Immune Deficiency or epidermolysis bullosa.
- C16 Biosciences is a company that uses synthetic biology to create lab-grown palm oil that is cheaper and better for the planet.
- Ecovative is a biotech firm that uses mycelium biofabrication platform to build sustainable materials.
- Synthetic biology is also being used to make "green chemicals" out of agricultural waste at the Unversity Center for Surfactants at Columbia University.
- In Sweden, over 4,000 people have been implanted with NFC chips that allow them to open doors, or serve as access cards.
Other Relevant Information
- Recent developments in the intersection of biology and technology have occurred in fields like biotechnology, bioinformatics, and synthetic biology.
Proposed next steps:
You need to be the project owner to select a next step.